menu
    • menu

    Company profile for LumiraDx

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. These included Medisense, Inverness Medical and Alere.As industry leading innovators, we have developed a state-of-the-art Platform, to deliver high accuracy diagnostics for community-based healthcare. Providing simple, accessible, and affordable point of care testing.We make dia...
    LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. These included Medisense, Inverness Medical and Alere.As industry leading innovators, we have developed a state-of-the-art Platform, to deliver high accuracy diagnostics for community-based healthcare. Providing simple, accessible, and affordable point of care testing.We make diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions to enable better outcomes: better health, better experiences and better value.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LumiraDxunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    3 More London Riverside London, SE1 2AQ
    Telephone
    Telephone
    0920612
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lumiradx.com/in-en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lumiradx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/lumiradx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq
    LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq

    05 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/05/2804902/0/en/LumiraDx-Announces-its-Securities-will-be-Suspended-from-Trading-on-Nasdaq-at-the-Open-of-Business-on-January-9th.html

    GLOBENEWSWIRE
    05 Jan 2024
    Share Share
    Roche to buy part of LumiraDx diagnostics platform for $295 million
    Roche to buy part of LumiraDx diagnostics platform for $295 million

    29 Dec 2023

    // REUTERS

    https://www.reuters.com/markets/deals/roche-buy-part-lumiradx-diagnostics-platform-295-million-2023-12-29/

    REUTERS
    29 Dec 2023
    Share Share
    LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal
    LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal

    27 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/27/2768716/0/en/LumiraDx-Announces-Receipt-of-NASDAQ-Delisting-Determination-Plans-to-Appeal.html

    GLOBENEWSWIRE
    27 Oct 2023
    Share Share
    LumiraDx Partners with AstraZeneca & Everton
    LumiraDx Partners with AstraZeneca & Everton

    20 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/20/2764275/0/en/LumiraDx-Partners-with-AstraZeneca-Everton-in-the-Community-to-Set-Up-England-s-First-Heart-Lung-Screening-Hub.html

    GLOBENEWSWIRE
    20 Oct 2023
    Share Share
    LumiraDx Reports Second Quarter 2023 Results
    LumiraDx Reports Second Quarter 2023 Results

    24 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/24/2731059/0/en/LumiraDx-Reports-Second-Quarter-2023-Results.html

    GLOBENEWSWIRE
    24 Aug 2023
    Share Share
    LumiraDx to Announce Second Quarter Financial Results
    LumiraDx to Announce Second Quarter Financial Results

    16 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/16/2726813/0/en/LumiraDx-to-Announce-Second-Quarter-Financial-Results-and-Host-Quarterly-Conference-Call-on-August-24.html

    GLOBENEWSWIRE
    16 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search